$54.05 +0.03 (%) Merck & Co Inc - NYSE

Oct. 20, 2014 | 04:00 PM

Partner Headlines

  1. What is Abner Herrman Investing In?

    GuruFocus | Oct. 16, 2014 | 15:59PM EST
  2. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  3. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD | Oct. 13, 2014 | 16:33PM EST
  4. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
  5. Merck to release hep C data

    IBD | Oct. 8, 2014 | 18:38PM EST
  6. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  7. Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo

    IBD | Oct. 7, 2014 | 11:13AM EST
  8. 2 Mutual Funds Holding Hospital Stocks

    Benzinga | Oct. 6, 2014 | 10:38AM EST
  9. Will Gilead Sciences Score Healthy Gains For Investors?

    IBD | Oct. 2, 2014 | 13:03PM EST
  10. J&J Buying Alios, Going Up Against Gilead

    IBD | Sep. 30, 2014 | 12:02PM EST
  11. Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader

    Benzinga | Sep. 29, 2014 | 13:31PM EST
  12. Reasons Why I Will Bet on Sigma

    GuruFocus | Sep. 26, 2014 | 16:27PM EST
  13. Fast Money Halftime Report Final Trade From September 26 - Merck & Co., Inc., NCR Corporation And BP plc

    Benzinga | Sep. 26, 2014 | 14:26PM EST
  14. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  15. 5 Big Deals Lifting German M&A In U.S. To Record High

    IBD | Sep. 22, 2014 | 17:57PM EST
  16. Citigroup Inc, Hertz Global Holdings, Inc. Highlight Fast Money Halftime Report Final Trade From September 22

    Benzinga | Sep. 22, 2014 | 14:54PM EST
  17. Sigma-Aldrich Hits High On Sale To Germany's Merck

    IBD | Sep. 22, 2014 | 11:30AM EST
  18. Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes

    Benzinga | Sep. 17, 2014 | 09:34AM EST
  19. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 16:58PM EST
  20. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 15:16PM EST
  21. Is Merck & Co., Inc. A Leader In A Red Hot Market?

    Benzinga | Sep. 10, 2014 | 14:50PM EST
  22. Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug

    Benzinga | Sep. 5, 2014 | 16:04PM EST
  23. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  24. 4 Biotechs That Might Be Bought Soon

    IBD | Aug. 29, 2014 | 11:53AM EST
  25. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  26. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  27. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  28. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga | Aug. 27, 2014 | 15:22PM EST
  29. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  30. UPDATE: Deutsche Bank Initiates Coverage On Merck

    Benzinga | Aug. 27, 2014 | 09:17AM EST
  31. Merck, Pfizer combining drugs

    IBD | Aug. 26, 2014 | 18:45PM EST
  32. Fast Money Halftime Report Final Trade From August 26

    Benzinga | Aug. 26, 2014 | 14:23PM EST
  33. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  34. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen

    Benzinga | Aug. 26, 2014 | 08:01AM EST
  35. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | Aug. 25, 2014 | 07:28AM EST
  36. Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer

    Benzinga | Aug. 25, 2014 | 05:26AM EST
  37. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD | Aug. 18, 2014 | 13:52PM EST
  38. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD | Aug. 15, 2014 | 18:10PM EST
  39. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD | Aug. 15, 2014 | 12:23PM EST
  40. Stocks Backslide Into Losses; Jazz Pharma, Kinder Morgan Rise

    IBD | Aug. 15, 2014 | 11:48AM EST
  41. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts | Aug. 14, 2014 | 15:57PM EST
  42. Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP Recommendations

    Benzinga | Aug. 13, 2014 | 18:00PM EST
  43. UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid

    Benzinga | Aug. 13, 2014 | 16:50PM EST
  44. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD | Aug. 12, 2014 | 10:48AM EST
  45. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus | Aug. 8, 2014 | 18:57PM EST
  46. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga | Aug. 4, 2014 | 12:55PM EST
  47. 3 Reasons to Buy Merck for the Long Term

    Benzinga | Jul. 31, 2014 | 15:30PM EST
  48. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD | Jul. 31, 2014 | 14:12PM EST
  49. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD | Jul. 30, 2014 | 19:01PM EST
  50. Amgen To Slash Workforce

    IBD | Jul. 29, 2014 | 19:05PM EST
Trading Center